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Paraneoplastic pemphigus (PNP) is caused by humoral 
and cell-mediated autoimmune reactions (1). On the 
other hand, Stevens Johnson syndrome (SJS) and toxic 
epidermal necrolysis (TEN) are related to drug-specific 
T-cell-mediated cytotoxicity. We present here a rare case 
of PNP mimicking TEN, which was treated with plasma 
exchange (PE) and showed that a cell-mediated immu-
nity has a significant role in the pathogenesis of TEN/
SJS-like PNP.
CASE REPORT
A 67-year-old Japanese woman without medication history no-
ticed erythema on her trunk and hands and lip erosions in 2017. 
The erythema spread to her whole body within one month. She 
presented with fever of approximately 38°C, eye discharge, eye 
pseudo-membranes, and confluent target-like and maculopapular 
erythema (Fig. 1a). Laboratory investigation revealed elevated 
levels of soluble interleukin (IL)-2 receptor (1,830 U/ml). Blood 
cell counts and serum lactate dehydrogenase were within normal 
limits. No active infections, including Mycoplasma pneumonia 
and herpes simplex virus, were observed. Antibody against human 
T-cell leukaemia virus type 1 was negative. Histopathological 
examination on the upper arm showed necrotic keratinocytes in 
the epidermis and vacuolar degeneration of the basement mem-
brane zone with mononuclear cell infiltration (Fig. 1b). Computed 
tomography scan showed a soft shadow behind the pancreas and 
a slight enlargement of lymph nodes, with a size of up to 14 mm, 
in the neck, axilla, lesser curvature of stomach, and mesocolon. 
We regarded this as reactive lymphadenopathy due to cutaneous 
inflammation. We initially diagnosed her with SJS. Various 
treatments were given, including oral prednisolone (1 mg/kg), 
and intravenous immunoglobulin (IVIG; 400 mg/kg for 5 days). 
However, further erosions appeared (Fig. 1c), and a second skin 
biopsy showed epidermal necrosis (Fig. 1d). Moreover, erosions 
developed on more than 30% of the patient’s entire body surface 
area (Fig. 1e). Therefore, we diagnosed TEN.
The patient was treated with PE 8 times from 7 days after hos-
pitalization; however, the erosions spread further, and she died 
due to septic shock. Autopsy revealed follicular lymphoma in 
the lymph nodes. Direct immunofluorescence (DIF) and indirect 
immunofluorescence (IIF) assays revealed linear IgG deposition 
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Fig. 1. (a) Clinical presentation at first visit. (b) Histopathological examination on the upper arm at first (haematoxylin-eosin (H&E) ×40). (c) 
After 2 days, erosions appeared. (d) The second skin biopsy on the abdomen (H&E×40). (e) Erosions appeared on more than 30% of the body surface 
area. (f) Indirect immunofluorescence (IIF) revealed IgG deposition. (g) Immunoblot analysis (lane 7, on admission; lane 8, before plasma exchange 
(PE); lane 9, after PE). Serum on admission reacted with PP (lane 7). Before PE, serum reacted with PP and envoplakin (EP) (lane 8). After PE, serum 
remained to react with periplakin (PP) and EP (lane 9). Sera of control, bullous pemphigoid (BP) 180, BP230, PNP, and desmoglein (Dsg)1 and Dsg3 
monoclonal antibodies are shown in lanes 1 to 6, respectively. Molecular weights are indicated on the left. (h, i) Immunohistochemical staining of the 
first biopsy revealed more CD8+ lymphocytes than CD4+ cells infiltrated into epidermis (amino-9-ethylcarbazole (AEC), CD8 (h), CD4 (i) staining ×200). 


























































on the basement membrane zone. IIF using rat bladder epithelial 
cells revealed IgG deposition (Fig. 1f). The index values of anti-
desmoglein 1 (Dsg1) and 3 (Dsg3) antibodies were 49.3 and 81.2, 
respectively, by enzyme-linked immunosorbent assay (ELISA). 
Immunoblot (IB) analysis was performed for 3 serum samples 
collected at different time courses using normal human epidermal 
extract, which detected 210-kDa envoplakin (EP) and 190-kDa 
periplakin (PP) (Fig. 1g). Therefore, we finally diagnosed the 
patient with TEN/SJS-like PNP associated with subclinical fol-
licular lymphoma. Dsg1 and Dsg3 were negative by IB analysis. 
Autoantibody against 210-kDa EP appeared, and the band of 
190-kDa PP became clearer after IVIG. ELISA revealed that the 
antibody titre indexes of Dsg1 and Dsg3 remained similar on day 
14 and decreased on day 16 (Fig. S11). However, the skin erosions 
spread day by day. We concluded that PE could not improve TEN/
SJS-like PNP.
DISCUSSION
To our knowledge, there have been only 9 case reports 
of TEN/SJS-like PNP published in English, including the 
case reported here (2–8), although a systematic review 
showed TEN-like PNP patients were 11.8% of the total 
cases of PNP and have a poor prognosis (9). Eight cases 
had anti-Dsg 3 antibody or autoantibody against EP. In 
order to distinguish between PNP and TEN/SJS-like PNP, 
it is important to search for haematological malignancy, 
and to perform ELISA and IB analysis (8). All of the cases 
had malignancy. In addition, 7 cases were related to hae-
matological malignancy. In 7 cases, the malignancy could 
not be surgically removed. Four cases were treated with 
PE; however, not all patients survived (8). Auto antibodies 
were evaluated several times during the course in only 2 
cases, including the current case (7). Although PE is as-
sumed to be effective for TEN patients due to the removal 
of inflammatory cytokines, it appears to be difficult to treat 
TEN/SJS-like PNP with PE. To treat PNP patients with 
PE without treating their cancers would be equivalent 
to treating TEN patients with PE without discontinuing 
causative drugs. It is desirable to detect and treat cancers 
before eruptions spread to the whole body. Considering 
the tolerability of cancer patients for invasive treatments, 
it is important to make careful decisions about treating 
TEN/SJS-like PNP patients with PE. 
It has only been reported in mouse studies that PNP 
is associated not only with humoral, but also with cell-
mediated, autoimmune reactions (1). Although there are 
some reports of PNP in which either immunoblot analysis 
or immunohistochemical analysis were performed (7, 10), 
there are no reports of human TEN/SJS-like PNP in which 
both immunoblot analysis and immunohistochemical 
staining were performed before and after PE. Transitions 
of both immunoblot analysis and immunohistochemical 
staining were important in order to evaluate how PE af-
fects patients with PNP, because PNP is associated with 
both humoral and cell-mediated autoimmune reactions 
(1). We hypothesize that cell-mediated immunity plays 
a major role in the pathogenesis of TEN/SJS-like PNP, 
as skin erosions spread, despite reduction in cytokines 
and autoantibodies with repeated PE in the current case 
and another case report (5). In the current case, immuno-
histochemical staining revealed that more CD8+ cells 
had infiltrated into the epidermis than CD4+ cells in the 
first biopsy specimen (Fig. 1h, 1i). Some reports of PNP 
show that more CD4+ cells infiltrated into the epidermis 
than CD8+ cells (10). CD4+ and CD8+ cells produce 
interferon-γ, and CD8+ cells secrete cytotoxic molecules 
(11). It is possible that the predominance of CD8+ cells 
might mean a predominance of cell-mediated immunity. 
In this case, CD8+ cells in the epidermis did not decrease 
after PE (Fig. 1j), which could explain the insufficiency 
of PE for TEN/SJS-like PNP. It is difficult to confirm this 
result in many cases, and further investigations, such as 
using tissue from biobanks, are required.
We consider that some TEN patients might be diagno-
sed with PNP if more investigations were carried out. In 
case of SJS/TEN-like patients without specific medica-
tion history, the possibility of PNP should be considered, 
and systemic evaluation for haematological malignancy, 
ELISA tests and IB analysis performed.
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